Phase 3, randomized trial (CheckMate 017) of nivolumab (NIVO) vs docetaxel in advanced squamous (SQ) cell non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Reckamp, K.; Brahmer, J. R.; Spigel, D. R.; Rizvi, N. A.; Poddubskaya, E.; West, H.; Eberhardt, W. E. E.; Baas, P.; Antonia, S. J.; Pluzanski, A.; Vokes, E.; Holgado, E.; Waterhouse, D.; Ready, N.; Gainor, J. F.; Frontera, O. A.; Horn, L.; Paz-Ares, L.; Li, A.; Lynch, M. |
| Abstract Title: | Phase 3, randomized trial (CheckMate 017) of nivolumab (NIVO) vs docetaxel in advanced squamous (SQ) cell non-small cell lung cancer (NSCLC) |
| Meeting Title: | 16th World Conference on Lung Cancer (WCLC) |
| Keywords: | immunotherapy; pd-l1; nivolumab; squamous cell nsclc |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 10 |
| Issue: | 9 Suppl. 2 |
| Meeting Dates: | 2015 Sep 6-9 |
| Meeting Location: | Denver, CO |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S174 |
| End Page: | S175 |
| Language: | English |
| ACCESSION: | WOS:000370365100214 |
| PROVIDER: | wos |
| PUBMED: | 26710300 |
| DOI: | 10.1016/S1556-0864(16)30010-7 |
| Notes: | Meeting Abstract: ORAL02.01 -- Source: Wos |
